Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE-4): Alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department.
Borgundvaag B, Bellolio F, Miles I, Schwarz ES, Sharif S, Su MK, Baumgartner K, Liss DB, Sheikh H, Vogel J, Austin EB, Upadhye S, Klaiman M, Vellend R, Munkley A, Carpenter CR.
Acad Emerg Med. 2024 May;31(5):425-455. doi: 10.1111/acem.14911.
A Systematic Review on Cannabis Hyperemesis Syndrome and Its Management Options.
Senderovich H, Patel P, Jimenez Lopez B, Waicus S.
Med Princ Pract. 2022;31(1):29-38. doi: 10.1159/000520417. Epub 2021 Nov 1.
Cocaine psychosis.
Baker FM.
J Natl Med Assoc. 1989 Sep;81(9):987, 990, 993-6, passim.
Managing cannabinoid hyperemesis syndrome in adult patients in the emergency department.
Won KJ, Celmins L.
Am J Health Syst Pharm. 2025 Dec 5;82(24):1340-1352. doi: 10.1093/ajhp/zxaf125.
Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial.
Ruberto AJ, Sivilotti MLA, Forrester S, Hall AK, Crawford FM, Day AG.
Ann Emerg Med. 2021 Jun;77(6):613-619. doi: 10.1016/j.annemergmed.2020.08.021. Epub 2020 Nov 5.
[Austrian syndrome].
Subirà C, Pérez H, Anglada M, López J.
Med Intensiva. 2010 Mar;34(2):155-6. doi: 10.1016/j.medin.2009.02.002. Epub 2009 Sep 23.
Zieve's syndrome.
Benraad HB, Penn HJ, Pieters GF, Tan HS.
J R Coll Physicians Lond. 1977 Oct;12(1):42-52.
Cannabinoid hyperemesis syndrome: A 6-year audit of adult presentations to an urban district hospital.
Rotella JA, Ferretti OG, Raisi E, Seet HR, Sarkar S.
Emerg Med Australas. 2022 Aug;34(4):578-583. doi: 10.1111/1742-6723.13944. Epub 2022 Feb 23.
Puffy hand syndrome.
Vivaldelli E, Sansone S, Maier A, Wiedermann CJ.
Lancet. 2017 Jan 21;389(10066):298. doi: 10.1016/S0140-6736(16)31011-X. Epub 2016 Aug 11.
Puffy hand syndrome.
Kovács AL, Rózsa A, Kálmán E, Gyömörei C, Schmidt E, Gyulai R.
Eur J Dermatol. 2017 Aug 1;27(4):415-417. doi: 10.1684/ejd.2017.3028.
